Press Release
Jim Faulkner, Nicole Mather and Carolyn Porter join the Cell and Gene Therapy Catapult as Non-Executive Directors£17.9m for Advanced Therapy Treatment Centre network to bolster clinical trial infrastructure in the UK: NIHR, Innovate UK and CGT Catapult align strategically to further improve patient access and the UK’s leadershipBraintree Manufacturing Innovation Centre receives MHRA licence to manufacture advanced therapiesEducation Secretary joins Cell and Gene Therapy Catapult to celebrate apprenticesUK maintains its position as an attractive destination for advanced therapy clinical trialsCell and Gene Therapy Catapult announces successful renewal of its five-year funding from Innovate UK to further support the advanced therapies sector